Liquid Biopsy Assessment of Molecular Residual Disease in Localized Colorectal Cancer: Is It Ready for Prime Time?

JAMA Oncol. 2023 Jun 1;9(6):763-764. doi: 10.1001/jamaoncol.2023.0329.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Circulating Tumor DNA*
  • Colorectal Neoplasms* / diagnosis
  • Humans
  • Liquid Biopsy

Substances

  • Circulating Tumor DNA